nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—skin cancer	0.448	1	CbGaD
Etodolac—ALB—Vismodegib—skin cancer	0.121	0.348	CbGbCtD
Etodolac—ALB—Vemurafenib—skin cancer	0.096	0.275	CbGbCtD
Etodolac—CYP2C9—Vismodegib—skin cancer	0.0655	0.187	CbGbCtD
Etodolac—ALB—Fluorouracil—skin cancer	0.0431	0.123	CbGbCtD
Etodolac—CYP2C9—Fluorouracil—skin cancer	0.0233	0.0666	CbGbCtD
Etodolac—PTGS2—leg—skin cancer	0.000779	0.1	CbGeAlD
Etodolac—PTGS2—hindlimb—skin cancer	0.000696	0.0893	CbGeAlD
Etodolac—PTGS2—appendage—skin cancer	0.000597	0.0766	CbGeAlD
Etodolac—RXRA—female reproductive system—skin cancer	0.000568	0.0729	CbGeAlD
Etodolac—PTGS2—skin epidermis—skin cancer	0.000497	0.0637	CbGeAlD
Etodolac—RXRA—head—skin cancer	0.000474	0.0609	CbGeAlD
Etodolac—UGT2B7—female reproductive system—skin cancer	0.000385	0.0494	CbGeAlD
Etodolac—PTGS1—endothelium—skin cancer	0.000377	0.0484	CbGeAlD
Etodolac—Haemorrhage—Temozolomide—skin cancer	0.00037	0.0019	CcSEcCtD
Etodolac—Hepatitis—Temozolomide—skin cancer	0.00037	0.0019	CcSEcCtD
Etodolac—Conjunctivitis—Fluorouracil—skin cancer	0.00037	0.00189	CcSEcCtD
Etodolac—Asthenia—Vemurafenib—skin cancer	0.00037	0.00189	CcSEcCtD
Etodolac—Hallucination—Temozolomide—skin cancer	0.000369	0.00189	CcSEcCtD
Etodolac—Pharyngitis—Temozolomide—skin cancer	0.000368	0.00188	CcSEcCtD
Etodolac—Chills—Dactinomycin—skin cancer	0.000368	0.00188	CcSEcCtD
Etodolac—Pruritus—Vemurafenib—skin cancer	0.000364	0.00187	CcSEcCtD
Etodolac—Alopecia—Dactinomycin—skin cancer	0.000362	0.00186	CcSEcCtD
Etodolac—Feeling abnormal—Imiquimod—skin cancer	0.000362	0.00185	CcSEcCtD
Etodolac—PTGS2—endothelium—skin cancer	0.00036	0.0462	CbGeAlD
Etodolac—Gastrointestinal pain—Imiquimod—skin cancer	0.000359	0.00184	CcSEcCtD
Etodolac—Visual impairment—Temozolomide—skin cancer	0.000357	0.00183	CcSEcCtD
Etodolac—Sinusitis—Fluorouracil—skin cancer	0.000357	0.00183	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000356	0.00183	CcSEcCtD
Etodolac—Agranulocytosis—Fluorouracil—skin cancer	0.000355	0.00182	CcSEcCtD
Etodolac—Ill-defined disorder—Bleomycin—skin cancer	0.000355	0.00182	CcSEcCtD
Etodolac—Anaemia—Bleomycin—skin cancer	0.000353	0.00181	CcSEcCtD
Etodolac—Diarrhoea—Vemurafenib—skin cancer	0.000352	0.00181	CcSEcCtD
Etodolac—Erythema multiforme—Temozolomide—skin cancer	0.00035	0.0018	CcSEcCtD
Etodolac—Urticaria—Imiquimod—skin cancer	0.000349	0.00179	CcSEcCtD
Etodolac—PTGS1—blood vessel—skin cancer	0.000348	0.0446	CbGeAlD
Etodolac—Abdominal pain—Imiquimod—skin cancer	0.000347	0.00178	CcSEcCtD
Etodolac—Body temperature increased—Imiquimod—skin cancer	0.000347	0.00178	CcSEcCtD
Etodolac—Tinnitus—Temozolomide—skin cancer	0.000345	0.00177	CcSEcCtD
Etodolac—Malaise—Bleomycin—skin cancer	0.000345	0.00177	CcSEcCtD
Etodolac—Flushing—Temozolomide—skin cancer	0.000344	0.00176	CcSEcCtD
Etodolac—Haemoglobin—Fluorouracil—skin cancer	0.000343	0.00176	CcSEcCtD
Etodolac—Leukopenia—Bleomycin—skin cancer	0.000342	0.00175	CcSEcCtD
Etodolac—Rhinitis—Fluorouracil—skin cancer	0.000342	0.00175	CcSEcCtD
Etodolac—Haemorrhage—Fluorouracil—skin cancer	0.000341	0.00175	CcSEcCtD
Etodolac—Dizziness—Vemurafenib—skin cancer	0.000341	0.00175	CcSEcCtD
Etodolac—Pharyngitis—Fluorouracil—skin cancer	0.000339	0.00174	CcSEcCtD
Etodolac—Chills—Temozolomide—skin cancer	0.000332	0.0017	CcSEcCtD
Etodolac—PTGS2—blood vessel—skin cancer	0.000332	0.0426	CbGeAlD
Etodolac—Ill-defined disorder—Dactinomycin—skin cancer	0.000331	0.0017	CcSEcCtD
Etodolac—Anaemia—Dactinomycin—skin cancer	0.00033	0.00169	CcSEcCtD
Etodolac—Vomiting—Vemurafenib—skin cancer	0.000327	0.00168	CcSEcCtD
Etodolac—Alopecia—Temozolomide—skin cancer	0.000327	0.00168	CcSEcCtD
Etodolac—Myalgia—Bleomycin—skin cancer	0.000326	0.00167	CcSEcCtD
Etodolac—Abdominal pain upper—Docetaxel—skin cancer	0.000325	0.00167	CcSEcCtD
Etodolac—Rash—Vemurafenib—skin cancer	0.000325	0.00166	CcSEcCtD
Etodolac—Dermatitis—Vemurafenib—skin cancer	0.000324	0.00166	CcSEcCtD
Etodolac—Hypersensitivity—Imiquimod—skin cancer	0.000324	0.00166	CcSEcCtD
Etodolac—Headache—Vemurafenib—skin cancer	0.000323	0.00165	CcSEcCtD
Etodolac—Discomfort—Bleomycin—skin cancer	0.000322	0.00165	CcSEcCtD
Etodolac—Malaise—Dactinomycin—skin cancer	0.000322	0.00165	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000321	0.00164	CcSEcCtD
Etodolac—Leukopenia—Dactinomycin—skin cancer	0.000319	0.00164	CcSEcCtD
Etodolac—Dysgeusia—Temozolomide—skin cancer	0.000316	0.00162	CcSEcCtD
Etodolac—Asthenia—Imiquimod—skin cancer	0.000315	0.00162	CcSEcCtD
Etodolac—Confusional state—Bleomycin—skin cancer	0.000315	0.00161	CcSEcCtD
Etodolac—Anaphylactic shock—Bleomycin—skin cancer	0.000312	0.0016	CcSEcCtD
Etodolac—Oedema—Bleomycin—skin cancer	0.000312	0.0016	CcSEcCtD
Etodolac—Pruritus—Imiquimod—skin cancer	0.000311	0.00159	CcSEcCtD
Etodolac—Infection—Bleomycin—skin cancer	0.00031	0.00159	CcSEcCtD
Etodolac—Nausea—Vemurafenib—skin cancer	0.000306	0.00157	CcSEcCtD
Etodolac—Thrombocytopenia—Bleomycin—skin cancer	0.000306	0.00157	CcSEcCtD
Etodolac—Arrhythmia—Fluorouracil—skin cancer	0.000305	0.00156	CcSEcCtD
Etodolac—Vision blurred—Temozolomide—skin cancer	0.000304	0.00156	CcSEcCtD
Etodolac—Myalgia—Dactinomycin—skin cancer	0.000304	0.00156	CcSEcCtD
Etodolac—Bronchospasm—Docetaxel—skin cancer	0.000303	0.00155	CcSEcCtD
Etodolac—Tremor—Temozolomide—skin cancer	0.000302	0.00155	CcSEcCtD
Etodolac—Alopecia—Fluorouracil—skin cancer	0.000302	0.00155	CcSEcCtD
Etodolac—Diarrhoea—Imiquimod—skin cancer	0.000301	0.00154	CcSEcCtD
Etodolac—Discomfort—Dactinomycin—skin cancer	0.0003	0.00154	CcSEcCtD
Etodolac—Ill-defined disorder—Temozolomide—skin cancer	0.000299	0.00153	CcSEcCtD
Etodolac—Anaemia—Temozolomide—skin cancer	0.000298	0.00153	CcSEcCtD
Etodolac—Anorexia—Bleomycin—skin cancer	0.000297	0.00152	CcSEcCtD
Etodolac—Angioedema—Temozolomide—skin cancer	0.000295	0.00151	CcSEcCtD
Etodolac—Pancytopenia—Docetaxel—skin cancer	0.000292	0.0015	CcSEcCtD
Etodolac—Hypotension—Bleomycin—skin cancer	0.000292	0.00149	CcSEcCtD
Etodolac—Oedema—Dactinomycin—skin cancer	0.000291	0.00149	CcSEcCtD
Etodolac—Malaise—Temozolomide—skin cancer	0.000291	0.00149	CcSEcCtD
Etodolac—Dizziness—Imiquimod—skin cancer	0.00029	0.00149	CcSEcCtD
Etodolac—Vertigo—Temozolomide—skin cancer	0.00029	0.00148	CcSEcCtD
Etodolac—Infection—Dactinomycin—skin cancer	0.000289	0.00148	CcSEcCtD
Etodolac—Leukopenia—Temozolomide—skin cancer	0.000289	0.00148	CcSEcCtD
Etodolac—Neutropenia—Docetaxel—skin cancer	0.000288	0.00148	CcSEcCtD
Etodolac—Palpitations—Temozolomide—skin cancer	0.000285	0.00146	CcSEcCtD
Etodolac—Thrombocytopenia—Dactinomycin—skin cancer	0.000285	0.00146	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000284	0.00146	CcSEcCtD
Etodolac—Paraesthesia—Bleomycin—skin cancer	0.00028	0.00144	CcSEcCtD
Etodolac—Vision blurred—Fluorouracil—skin cancer	0.00028	0.00144	CcSEcCtD
Etodolac—Convulsion—Temozolomide—skin cancer	0.000279	0.00143	CcSEcCtD
Etodolac—Vomiting—Imiquimod—skin cancer	0.000279	0.00143	CcSEcCtD
Etodolac—Hypertension—Temozolomide—skin cancer	0.000278	0.00143	CcSEcCtD
Etodolac—Dyspnoea—Bleomycin—skin cancer	0.000278	0.00143	CcSEcCtD
Etodolac—Anorexia—Dactinomycin—skin cancer	0.000277	0.00142	CcSEcCtD
Etodolac—Rash—Imiquimod—skin cancer	0.000277	0.00142	CcSEcCtD
Etodolac—Dermatitis—Imiquimod—skin cancer	0.000277	0.00142	CcSEcCtD
Etodolac—Pneumonia—Docetaxel—skin cancer	0.000276	0.00141	CcSEcCtD
Etodolac—Headache—Imiquimod—skin cancer	0.000275	0.00141	CcSEcCtD
Etodolac—Anaemia—Fluorouracil—skin cancer	0.000275	0.00141	CcSEcCtD
Etodolac—Arthralgia—Temozolomide—skin cancer	0.000275	0.00141	CcSEcCtD
Etodolac—Myalgia—Temozolomide—skin cancer	0.000275	0.00141	CcSEcCtD
Etodolac—Anxiety—Temozolomide—skin cancer	0.000274	0.0014	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000272	0.00139	CcSEcCtD
Etodolac—Discomfort—Temozolomide—skin cancer	0.000271	0.00139	CcSEcCtD
Etodolac—Decreased appetite—Bleomycin—skin cancer	0.000271	0.00139	CcSEcCtD
Etodolac—Acute coronary syndrome—Docetaxel—skin cancer	0.000271	0.00139	CcSEcCtD
Etodolac—Renal failure—Docetaxel—skin cancer	0.00027	0.00138	CcSEcCtD
Etodolac—Myocardial infarction—Docetaxel—skin cancer	0.000269	0.00138	CcSEcCtD
Etodolac—Dry mouth—Temozolomide—skin cancer	0.000269	0.00138	CcSEcCtD
Etodolac—Stomatitis—Docetaxel—skin cancer	0.000268	0.00137	CcSEcCtD
Etodolac—Jaundice—Docetaxel—skin cancer	0.000268	0.00137	CcSEcCtD
Etodolac—Pain—Bleomycin—skin cancer	0.000267	0.00137	CcSEcCtD
Etodolac—Conjunctivitis—Docetaxel—skin cancer	0.000267	0.00137	CcSEcCtD
Etodolac—Leukopenia—Fluorouracil—skin cancer	0.000266	0.00136	CcSEcCtD
Etodolac—Confusional state—Temozolomide—skin cancer	0.000265	0.00136	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000265	0.00136	CcSEcCtD
Etodolac—Anaphylactic shock—Temozolomide—skin cancer	0.000263	0.00135	CcSEcCtD
Etodolac—Oedema—Temozolomide—skin cancer	0.000263	0.00135	CcSEcCtD
Etodolac—Infection—Temozolomide—skin cancer	0.000261	0.00134	CcSEcCtD
Etodolac—Nausea—Imiquimod—skin cancer	0.000261	0.00134	CcSEcCtD
Etodolac—Thrombocytopenia—Temozolomide—skin cancer	0.000258	0.00132	CcSEcCtD
Etodolac—Convulsion—Fluorouracil—skin cancer	0.000257	0.00132	CcSEcCtD
Etodolac—Feeling abnormal—Bleomycin—skin cancer	0.000257	0.00132	CcSEcCtD
Etodolac—Agranulocytosis—Docetaxel—skin cancer	0.000256	0.00131	CcSEcCtD
Etodolac—Hyperhidrosis—Temozolomide—skin cancer	0.000254	0.0013	CcSEcCtD
Etodolac—Myalgia—Fluorouracil—skin cancer	0.000253	0.0013	CcSEcCtD
Etodolac—Decreased appetite—Dactinomycin—skin cancer	0.000253	0.0013	CcSEcCtD
Etodolac—PTGS1—nipple—skin cancer	0.000251	0.0323	CbGeAlD
Etodolac—Fatigue—Dactinomycin—skin cancer	0.000251	0.00129	CcSEcCtD
Etodolac—Anorexia—Temozolomide—skin cancer	0.000251	0.00129	CcSEcCtD
Etodolac—Discomfort—Fluorouracil—skin cancer	0.00025	0.00128	CcSEcCtD
Etodolac—Pain—Dactinomycin—skin cancer	0.000249	0.00128	CcSEcCtD
Etodolac—Urticaria—Bleomycin—skin cancer	0.000248	0.00127	CcSEcCtD
Etodolac—Haemoglobin—Docetaxel—skin cancer	0.000248	0.00127	CcSEcCtD
Etodolac—Rhinitis—Docetaxel—skin cancer	0.000247	0.00127	CcSEcCtD
Etodolac—Body temperature increased—Bleomycin—skin cancer	0.000247	0.00126	CcSEcCtD
Etodolac—Hepatitis—Docetaxel—skin cancer	0.000246	0.00126	CcSEcCtD
Etodolac—Haemorrhage—Docetaxel—skin cancer	0.000246	0.00126	CcSEcCtD
Etodolac—Confusional state—Fluorouracil—skin cancer	0.000245	0.00125	CcSEcCtD
Etodolac—Pharyngitis—Docetaxel—skin cancer	0.000245	0.00125	CcSEcCtD
Etodolac—Oedema—Fluorouracil—skin cancer	0.000243	0.00124	CcSEcCtD
Etodolac—Anaphylactic shock—Fluorouracil—skin cancer	0.000243	0.00124	CcSEcCtD
Etodolac—Infection—Fluorouracil—skin cancer	0.000241	0.00123	CcSEcCtD
Etodolac—Feeling abnormal—Dactinomycin—skin cancer	0.00024	0.00123	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00024	0.00123	CcSEcCtD
Etodolac—Insomnia—Temozolomide—skin cancer	0.000238	0.00122	CcSEcCtD
Etodolac—Gastrointestinal pain—Dactinomycin—skin cancer	0.000238	0.00122	CcSEcCtD
Etodolac—Thrombocytopenia—Fluorouracil—skin cancer	0.000237	0.00122	CcSEcCtD
Etodolac—Visual impairment—Docetaxel—skin cancer	0.000237	0.00122	CcSEcCtD
Etodolac—Tachycardia—Fluorouracil—skin cancer	0.000237	0.00121	CcSEcCtD
Etodolac—Paraesthesia—Temozolomide—skin cancer	0.000236	0.00121	CcSEcCtD
Etodolac—Dyspnoea—Temozolomide—skin cancer	0.000235	0.0012	CcSEcCtD
Etodolac—Somnolence—Temozolomide—skin cancer	0.000234	0.0012	CcSEcCtD
Etodolac—Erythema multiforme—Docetaxel—skin cancer	0.000233	0.00119	CcSEcCtD
Etodolac—Dyspepsia—Temozolomide—skin cancer	0.000232	0.00119	CcSEcCtD
Etodolac—Anorexia—Fluorouracil—skin cancer	0.000231	0.00118	CcSEcCtD
Etodolac—Abdominal pain—Dactinomycin—skin cancer	0.00023	0.00118	CcSEcCtD
Etodolac—Body temperature increased—Dactinomycin—skin cancer	0.00023	0.00118	CcSEcCtD
Etodolac—Hypersensitivity—Bleomycin—skin cancer	0.00023	0.00118	CcSEcCtD
Etodolac—Decreased appetite—Temozolomide—skin cancer	0.000229	0.00117	CcSEcCtD
Etodolac—Flushing—Docetaxel—skin cancer	0.000229	0.00117	CcSEcCtD
Etodolac—Fatigue—Temozolomide—skin cancer	0.000227	0.00116	CcSEcCtD
Etodolac—Hypotension—Fluorouracil—skin cancer	0.000227	0.00116	CcSEcCtD
Etodolac—Pain—Temozolomide—skin cancer	0.000225	0.00115	CcSEcCtD
Etodolac—Constipation—Temozolomide—skin cancer	0.000225	0.00115	CcSEcCtD
Etodolac—Asthenia—Bleomycin—skin cancer	0.000224	0.00115	CcSEcCtD
Etodolac—Chills—Docetaxel—skin cancer	0.000221	0.00113	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000221	0.00113	CcSEcCtD
Etodolac—Pruritus—Bleomycin—skin cancer	0.000221	0.00113	CcSEcCtD
Etodolac—Arrhythmia—Docetaxel—skin cancer	0.00022	0.00113	CcSEcCtD
Etodolac—Insomnia—Fluorouracil—skin cancer	0.000219	0.00112	CcSEcCtD
Etodolac—Paraesthesia—Fluorouracil—skin cancer	0.000218	0.00112	CcSEcCtD
Etodolac—Alopecia—Docetaxel—skin cancer	0.000218	0.00112	CcSEcCtD
Etodolac—Feeling abnormal—Temozolomide—skin cancer	0.000217	0.00111	CcSEcCtD
Etodolac—Dyspnoea—Fluorouracil—skin cancer	0.000216	0.00111	CcSEcCtD
Etodolac—Somnolence—Fluorouracil—skin cancer	0.000216	0.0011	CcSEcCtD
Etodolac—Gastrointestinal pain—Temozolomide—skin cancer	0.000215	0.0011	CcSEcCtD
Etodolac—Hypersensitivity—Dactinomycin—skin cancer	0.000214	0.0011	CcSEcCtD
Etodolac—Dyspepsia—Fluorouracil—skin cancer	0.000213	0.00109	CcSEcCtD
Etodolac—Decreased appetite—Fluorouracil—skin cancer	0.000211	0.00108	CcSEcCtD
Etodolac—Dysgeusia—Docetaxel—skin cancer	0.00021	0.00108	CcSEcCtD
Etodolac—Urticaria—Temozolomide—skin cancer	0.000209	0.00107	CcSEcCtD
Etodolac—Asthenia—Dactinomycin—skin cancer	0.000209	0.00107	CcSEcCtD
Etodolac—Abdominal pain—Temozolomide—skin cancer	0.000208	0.00107	CcSEcCtD
Etodolac—Body temperature increased—Temozolomide—skin cancer	0.000208	0.00107	CcSEcCtD
Etodolac—Pain—Fluorouracil—skin cancer	0.000207	0.00106	CcSEcCtD
Etodolac—Feeling abnormal—Fluorouracil—skin cancer	0.0002	0.00102	CcSEcCtD
Etodolac—Diarrhoea—Dactinomycin—skin cancer	0.000199	0.00102	CcSEcCtD
Etodolac—Vomiting—Bleomycin—skin cancer	0.000198	0.00102	CcSEcCtD
Etodolac—Anaemia—Docetaxel—skin cancer	0.000198	0.00102	CcSEcCtD
Etodolac—Rash—Bleomycin—skin cancer	0.000197	0.00101	CcSEcCtD
Etodolac—Dermatitis—Bleomycin—skin cancer	0.000197	0.00101	CcSEcCtD
Etodolac—Hypersensitivity—Temozolomide—skin cancer	0.000194	0.000994	CcSEcCtD
Etodolac—Urticaria—Fluorouracil—skin cancer	0.000193	0.000987	CcSEcCtD
Etodolac—Syncope—Docetaxel—skin cancer	0.000192	0.000986	CcSEcCtD
Etodolac—Leukopenia—Docetaxel—skin cancer	0.000192	0.000984	CcSEcCtD
Etodolac—Body temperature increased—Fluorouracil—skin cancer	0.000192	0.000983	CcSEcCtD
Etodolac—Palpitations—Docetaxel—skin cancer	0.00019	0.000971	CcSEcCtD
Etodolac—Asthenia—Temozolomide—skin cancer	0.000189	0.000968	CcSEcCtD
Etodolac—Loss of consciousness—Docetaxel—skin cancer	0.000189	0.000966	CcSEcCtD
Etodolac—Pruritus—Temozolomide—skin cancer	0.000186	0.000954	CcSEcCtD
Etodolac—Convulsion—Docetaxel—skin cancer	0.000186	0.000952	CcSEcCtD
Etodolac—Nausea—Bleomycin—skin cancer	0.000185	0.00095	CcSEcCtD
Etodolac—Hypertension—Docetaxel—skin cancer	0.000185	0.000949	CcSEcCtD
Etodolac—Vomiting—Dactinomycin—skin cancer	0.000185	0.000948	CcSEcCtD
Etodolac—Rash—Dactinomycin—skin cancer	0.000183	0.00094	CcSEcCtD
Etodolac—Myalgia—Docetaxel—skin cancer	0.000183	0.000936	CcSEcCtD
Etodolac—Arthralgia—Docetaxel—skin cancer	0.000183	0.000936	CcSEcCtD
Etodolac—Diarrhoea—Temozolomide—skin cancer	0.00018	0.000923	CcSEcCtD
Etodolac—Hypersensitivity—Fluorouracil—skin cancer	0.000179	0.000916	CcSEcCtD
Etodolac—Dry mouth—Docetaxel—skin cancer	0.000179	0.000915	CcSEcCtD
Etodolac—PTGS1—connective tissue—skin cancer	0.000178	0.0229	CbGeAlD
Etodolac—Confusional state—Docetaxel—skin cancer	0.000176	0.000905	CcSEcCtD
Etodolac—Anaphylactic shock—Docetaxel—skin cancer	0.000175	0.000897	CcSEcCtD
Etodolac—Oedema—Docetaxel—skin cancer	0.000175	0.000897	CcSEcCtD
Etodolac—Dizziness—Temozolomide—skin cancer	0.000174	0.000892	CcSEcCtD
Etodolac—Infection—Docetaxel—skin cancer	0.000174	0.000891	CcSEcCtD
Etodolac—Nausea—Dactinomycin—skin cancer	0.000173	0.000886	CcSEcCtD
Etodolac—Shock—Docetaxel—skin cancer	0.000172	0.000883	CcSEcCtD
Etodolac—Pruritus—Fluorouracil—skin cancer	0.000172	0.000879	CcSEcCtD
Etodolac—Thrombocytopenia—Docetaxel—skin cancer	0.000171	0.000878	CcSEcCtD
Etodolac—Tachycardia—Docetaxel—skin cancer	0.000171	0.000876	CcSEcCtD
Etodolac—PTGS2—connective tissue—skin cancer	0.00017	0.0219	CbGeAlD
Etodolac—PTGS1—epithelium—skin cancer	0.000169	0.0217	CbGeAlD
Etodolac—Vomiting—Temozolomide—skin cancer	0.000167	0.000858	CcSEcCtD
Etodolac—Anorexia—Docetaxel—skin cancer	0.000167	0.000855	CcSEcCtD
Etodolac—Rash—Temozolomide—skin cancer	0.000166	0.000851	CcSEcCtD
Etodolac—Diarrhoea—Fluorouracil—skin cancer	0.000166	0.00085	CcSEcCtD
Etodolac—Dermatitis—Temozolomide—skin cancer	0.000166	0.00085	CcSEcCtD
Etodolac—Headache—Temozolomide—skin cancer	0.000165	0.000845	CcSEcCtD
Etodolac—Hypotension—Docetaxel—skin cancer	0.000164	0.000838	CcSEcCtD
Etodolac—PTGS2—epithelium—skin cancer	0.000162	0.0208	CbGeAlD
Etodolac—PTGS1—skin of body—skin cancer	0.000161	0.0207	CbGeAlD
Etodolac—Dizziness—Fluorouracil—skin cancer	0.00016	0.000822	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000159	0.000817	CcSEcCtD
Etodolac—Insomnia—Docetaxel—skin cancer	0.000158	0.000811	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—skin cancer	0.000157	0.000806	CcSEcCtD
Etodolac—Nausea—Temozolomide—skin cancer	0.000156	0.000801	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—skin cancer	0.000156	0.0008	CcSEcCtD
Etodolac—Somnolence—Docetaxel—skin cancer	0.000156	0.000798	CcSEcCtD
Etodolac—Vomiting—Fluorouracil—skin cancer	0.000154	0.00079	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—skin cancer	0.000154	0.00079	CcSEcCtD
Etodolac—PTGS2—skin of body—skin cancer	0.000154	0.0197	CbGeAlD
Etodolac—Rash—Fluorouracil—skin cancer	0.000153	0.000784	CcSEcCtD
Etodolac—Dermatitis—Fluorouracil—skin cancer	0.000153	0.000783	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—skin cancer	0.000152	0.00078	CcSEcCtD
Etodolac—Headache—Fluorouracil—skin cancer	0.000152	0.000779	CcSEcCtD
Etodolac—Fatigue—Docetaxel—skin cancer	0.000151	0.000773	CcSEcCtD
Etodolac—Pain—Docetaxel—skin cancer	0.00015	0.000767	CcSEcCtD
Etodolac—Constipation—Docetaxel—skin cancer	0.00015	0.000767	CcSEcCtD
Etodolac—PTGS1—mammalian vulva—skin cancer	0.000147	0.0188	CbGeAlD
Etodolac—Feeling abnormal—Docetaxel—skin cancer	0.000144	0.000739	CcSEcCtD
Etodolac—Nausea—Fluorouracil—skin cancer	0.000144	0.000738	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—skin cancer	0.000143	0.000734	CcSEcCtD
Etodolac—Body temperature increased—Docetaxel—skin cancer	0.000138	0.000709	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—skin cancer	0.000138	0.000709	CcSEcCtD
Etodolac—CYP2C9—female reproductive system—skin cancer	0.000138	0.0177	CbGeAlD
Etodolac—ALB—lymph node—skin cancer	0.000129	0.0166	CbGeAlD
Etodolac—Hypersensitivity—Docetaxel—skin cancer	0.000129	0.000661	CcSEcCtD
Etodolac—PTGS1—female reproductive system—skin cancer	0.000126	0.0161	CbGeAlD
Etodolac—Asthenia—Docetaxel—skin cancer	0.000126	0.000644	CcSEcCtD
Etodolac—PTGS2—lymphoid tissue—skin cancer	0.000125	0.016	CbGeAlD
Etodolac—Pruritus—Docetaxel—skin cancer	0.000124	0.000635	CcSEcCtD
Etodolac—PTGS2—female reproductive system—skin cancer	0.00012	0.0154	CbGeAlD
Etodolac—Diarrhoea—Docetaxel—skin cancer	0.00012	0.000614	CcSEcCtD
Etodolac—Dizziness—Docetaxel—skin cancer	0.000116	0.000593	CcSEcCtD
Etodolac—Vomiting—Docetaxel—skin cancer	0.000111	0.00057	CcSEcCtD
Etodolac—Rash—Docetaxel—skin cancer	0.00011	0.000566	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—skin cancer	0.00011	0.000565	CcSEcCtD
Etodolac—Headache—Docetaxel—skin cancer	0.00011	0.000562	CcSEcCtD
Etodolac—PTGS1—head—skin cancer	0.000105	0.0135	CbGeAlD
Etodolac—Nausea—Docetaxel—skin cancer	0.000104	0.000533	CcSEcCtD
Etodolac—PTGS2—head—skin cancer	0.0001	0.0129	CbGeAlD
Etodolac—PTGS1—lymph node—skin cancer	7.35e-05	0.00944	CbGeAlD
Etodolac—PTGS2—lymph node—skin cancer	7.03e-05	0.00902	CbGeAlD
